2014 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014
DateTitle 
12/10/14iRhythm Technologies, Inc. Awarded Ambulatory Health Care Accreditation from the Joint Commission
SAN FRANCISCO – December 10, 2014 – iRhythm Technologies, Inc, a leading digital health care solutions company focusing on the advancement of cardiac care, today announced that it has earned The Joint Commission's Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally-recognized standards. The Gold Seal of Approval® is a symbol of quality that reflects an organization's commitment to providing safe and... 
Printer Friendly Version
12/03/14iRhythm Technologies Receives CE Mark for ZIO® Service, Enters First International Market with CardioLogic Ltd Partnership in United Kingdom
San Francisco, Calif. --- December 3, 2014 --- iRhythm Technologies, Inc., a leading digital health care solutions company focusing on the advancement of cardiac care, today announced that it has secured a CE mark (Conformité Européenne) for the ZIO Service, enabling the company to market its long-term continuous heart monitoring solution in Europe. The company also announced its first international market entry through an exclusive agreement with CardioLogic Ltd, which will make ... 
Printer Friendly Version
12/01/14iRhythm Technologies to Present at the Piper Jaffray Healthcare Conference
SAN FRANCISCO – December 1, 2014 – iRhythm Technologies, Inc. today announced that Kevin King, president and chief executive officer, will present at the 26th Annual Piper Jaffray Healthcare Conference on December 2, 2014, at 2:30 p.m. Eastern Time. The conference is being held at the New York Palace Hotel in New York City. About iRhythm Technologies, Inc. iRhythm is a privately held digital healthcare company that aspires to be the world leader in... 
Printer Friendly Version
11/17/14New Study Demonstrates for the First Time High Burden of Atrial Fibrillation is Associated with Lower Cognitive Function
Data Presented Today at American Heart Association Scientific Sessions Shows iRhythm Technologies' ZIO® Patch Key to Determining True Atrial Fibrillation Burden Chicago, IL– November 17, 2014 – iRhythm Technologies, Inc.announced today that study results presented during the American Heart Association (AHA) Scientific Sessions showed an association between a high burden of atrial fibrillation (AFib) and lower cognitive function, specifically executive and verb... 
Printer Friendly Version
09/22/14September is National Atrial Fibrillation Awareness Month: Survey Shows Americans Lack Awareness About “Afib,” Its Risk Factors and Symptoms
SAN FRANCISCO – September 22, 2014 – In observation of National Atrial Fibrillation Awareness Month, a survey sponsored by iRhythm Technologies reveals that nearly half of Americans lack awareness about the primary symptoms of this common yet potentially deadly heart rhythm disturbance. Additionally, the survey of 1,013 American adults found that fewer than 20 percent of respondents could correctly identify medical conditions such as sleep apnea and diabetes as risk factors for ... 
Printer Friendly Version
09/22/14September is National Atrial Fibrillation Awareness Month: Americans Lack Awareness About Atrial Fibrillation and Stroke Risk
Centennial, CO – September 22, 2014 – National Stroke Association and iRhythm Technologies are observing National Atrial Fibrillation (Afib) Awareness Month with insights from a new survey evaluating public awareness of Afib. Approximately 2.7 million Americans are living with diagnosed Afib, and another 850,000 are estimated to have Afib and remain undiagnosed. Afib is an irregular heartbeat which may cause blood to collect in the heart and form a clot. These clots can travel t... 
Printer Friendly Version
05/22/14iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO® Service
SAN FRANCISCO – May 22, 2014 – iRhythm Technologies, Inc., a healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S, a global life science investment firm. Norwest Venture Partners, which led the company's Series D financing, also participated in the oversubscribed round. iRhythm's ZIO Service has been used with almost 250,000 patients at over 800 institutions nationwide, and is covered by leading public and priva... 
Printer Friendly Version
05/12/14Study Presentations at Heart Rhythm 2014 Support the Use of iRhythm's ZIO® Service to Detect Atrial Fibrillation, Other Cardiac Arrhythmias
SAN FRANCISCO – May 12, 2014 – iRhythm Technologies, Inc., a healthcare information services company, today announced that data from four studies presented recently at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions, support the use of the company's ZIO Service to identify atrial fibrillation (AF) and other cardiac arrhythmias. AF is the most common type of arrhythmia, affecting nearly 2.7 million people in the United States. Data show that AF ele... 
Printer Friendly Version
03/28/14New Study Demonstrates Clinical Utility of iRhythm’s ZIO® Service to Rule In and Rule Out Cardiac Arrhythmias in Discharged Emergency Department Patients
SAN FRANCISCO – March 28, 2014 – iRhythm Technologies, a healthcare information services company, today announced new study findings that demonstrate the clinical utility of the ZIO Service for ruling in and ruling out cardiac arrhythmias in patients suspected of having the condition, following their discharge from the hospital emergency department (ED). The new findings appear in the March issue of the Western Journal of Emergency Medicine. "Each year, millions of p... 
Printer Friendly Version
02/13/14New Data Support Use of iRhythm’s ZIO® Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients
SAN FRANCISCO – February 13, 2014 – iRhythm Technologies, Inc., a healthcare information services company, today announced that new study data support the use of its ZIO Service to help identify underlying cardiac arrhythmias in patients who have had a stroke or transient ischemic attack (TIA). The ZIO Service enables long-term continuous monitoring – using a noninvasive, small, wearable patch – to detect sporadic heart rhythm disturbances, including atrial fibrillation (AF), wh... 
Printer Friendly Version
01/30/14iRhythm Announces That ZIO® Service Included Under New Aetna Policy Covering Long-Term Continuous Monitoring of Patients With Suspected Heart Arrhythmias
SAN FRANCISCO – January 30, 2014 – iRhythm Technologies, a healthcare information services company, today announced that Aetna, the third largest health plan in the United States, has issued a positive coverage policy for long-term continuous monitoring of patients with suspected heart arrhythmias, which includes use of the ZIO Service. The new policy now makes iRhythm's solution – comprised of the ZIO Patch, proprietary algorithms and the ZIO report – available as a potential c... 
Printer Friendly Version
01/02/14ZIO® Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine
SAN FRANCISCO – January 2, 2014 – iRhythm Technologies, a healthcare information services company, today announced that a prospective study by Scripps Translational Science Institute (STSI) has found that use of the company's ZIO Service significantly increased detection of cardiac arrhythmias, compared to use of the traditional Holter monitor. The findings, published and made publicly accessible online in the January issue of the American Journal of Medicine, underscore the rol... 
Printer Friendly Version